y 27632 has been researched along with Uremia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, HR; Hsu, YH; Huang, HP | 1 |
Anfosso, F; Berland, Y; Brunet, P; Cerini, C; De Smet, R; Dignat-George, F; Dou, L; Glorieux, G; Moal, V; Sabatier, F; Sampol, J; Vanholder, R | 1 |
2 other study(ies) available for y 27632 and Uremia
Article | Year |
---|---|
The uremic toxin p-cresol promotes the invasion and migration on carcinoma cells via Ras and mTOR signaling.
Topics: Amides; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cresols; Everolimus; Humans; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pyridines; ras Proteins; Signal Transduction; TOR Serine-Threonine Kinases; Uremia; Urinary Bladder Neoplasms; Wound Healing | 2019 |
P-cresol, a uremic retention solute, alters the endothelial barrier function in vitro.
Topics: Actins; Amides; Antigens, CD; Cadherins; Capillary Permeability; Cells, Cultured; Cresols; Cytoskeleton; Endothelium, Vascular; Enzyme Inhibitors; Humans; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Kidney Failure, Chronic; Protein Serine-Threonine Kinases; Pyridines; rho-Associated Kinases; Uremia | 2004 |